Study Overview
This clinical trial focuses on testing the efficacy of different digital interventions to promote re-engagement in cancer-related long-term follow-up care for adolescent and young adult (AYA) survivors of childhood cancer.
Description
The purpose of this prospective observational study is to collect data from participants who have recently had an allogenic Stem Cell Transplant(alloSCT) and are at risk of Chronic Graft Versus Host Disease(cGVHD)
Official Title
A Prospective, Observational Cohort Study of Participants at Risk for Chronic Graft-Versus-Host Disease in the United States (THRIVE)
Quick Facts
Study Start:2023-08-02
Study Completion:2027-10-15
Study Type:Not specified
Phase:Not Applicable
Enrollment:Not specified
Status:RECRUITING
Participation Criteria
Researchers look for people who fit a certain description, called eligibility criteria. Some examples of these criteria are a person's general health condition or prior treatments.
| Inclusion Criteria | Exclusion Criteria |
|---|
| |
Contacts and Locations
Study Locations (Sites)
University of Alabama Birmingham
Birmingham, Alabama, 35294
United States
Mayo Clinic Arizona
Phoenix, Arizona, 85054
United States
City of Hope
Duarte, California, 91010
United States
USC Norris Comprehensive Cancer Center
Los Angeles, California, 90033
United States
University of Colorado
Aurora, Colorado, 80309
United States
Mayo Clinic Jacksonville
Jacksonville, Florida, 32224
United States
AdventHealth Orlando
Orlando, Florida, 32803
United States
Emory University
Atlanta, Georgia, 30322
United States
Northwestern University
Chicago, Illinois, 60611
United States
Rush University Medical Group
Chicago, Illinois, 60612
United States
The University of Kansas Clinical Research Center
Fairway, Kansas, 66205
United States
Tulane Cancer Center
New Orleans, Louisiana, 70112
United States
University of Maryland Medical Center
Baltimore, Maryland, 21201
United States
Massachusetts Cancer Research Center
Boston, Massachusetts, 02114
United States
Corewell Health
Grand Rapids, Michigan, 49503
United States
Mayo Clinic Rochester
Rochester, Minnesota, 55905
United States
Rutgers Cancer Institute of New Jersey
New Brunswick, New Jersey, 08602
United States
University of North Carolina at Chapel Hill
Chapel Hill, North Carolina, 27514
United States
Levine Cancer Institute
Charlotte, North Carolina, 28204
United States
The Ohio State University
Columbus, Ohio, 43201
United States
Vanderbilt University Medical Center
Nashville, Tennessee, 37212
United States
Texas Oncology-Baylor Charles A. Sammons Cancer Center
Dallas, Texas, 75246
United States
University of Utah, Huntsman Cancer Institute
Salt Lake City, Utah, 84112
United States
Fred Hutchinson Cancer Research Center
Seattle, Washington, 98109
United States
Medical College of Wisconsin
Milwaukee, Wisconsin, 53226
United States
Collaborators and Investigators
Sponsor: Incyte Corporation
Study Record Dates
These dates track the progress of study record and summary results submissions to ClinicalTrials.gov. Study records and reported results are reviewed by the National Library of Medicine (NLM) to make sure they meet specific quality control standards before being posted on the public website.
Study Registration Dates
Study Start Date2023-08-02
Study Completion Date2027-10-15
Study Record Updates
Study Start Date2023-08-02
Study Completion Date2027-10-15
Terms related to this study
Keywords Provided by Researchers
- chronic graft versus host disease
- cGVHD
- MA-GVHD-401
- THRIVE
- GVHD
- chronic GVHD
- allogenic stem cell transplant (alloSCT)
Additional Relevant MeSH Terms